Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica
- Substances:Secukinumab
France- Participants:18–64 years · 65+ years
- Substances:Secukinumab
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to France289 clinical trials in Le Mans, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
FranceStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
FranceStudy Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments
FranceStudy of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
FranceStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
FranceStudy on Stereotactic Body Radiation Therapy with or without Durvalumab for Patients with Oligometastatic Hormone-Sensitive Prostate Cancer
France
FranceStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
FranceStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
FranceStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
FranceStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
FranceStudy on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on multiple myeloma treatments, including evaluations of new combination therapies and maintenance approaches. Studies also explore treatments for head and neck cancers and advanced prostate cancer.
Several trials are investigating novel immunotherapy combinations and targeted treatments to improve patient outcomes.
Critical research in lung cancer and pleural mesothelioma, with studies evaluating immunotherapy combinations and novel treatment approaches for previously treated patients.
Focus on developing personalized treatment strategies for advanced respiratory cancers.
Comprehensive research into systemic lupus erythematosus and plaque psoriasis, evaluating new biological treatments and long-term therapeutic solutions.
Trials aim to improve treatment outcomes while maintaining patient safety and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.